Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical pharmacology of monoamine oxidase inhibitors.

× No keyword cloud information.

11 in total

Review 1. Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.

Authors: G B Baker; R T Coutts; K F McKenna; R L Sherry-McKenna
Journal: J Psychiatry Neurosci Date: 1992-11 Impact factor: 6.186

Review 2. Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studies.

Authors: R Amrein; T W Güntert; J Dingemanse; T Lorscheid; M Stabl; W Schmid-Burgk
Journal: Psychopharmacology (Berl) Date: 1992 Impact factor: 4.530

3. Monoamine oxidase inhibitors: clinical review.

Authors: R A Remick; C Froese
Journal: Can Fam Physician Date: 1990-06 Impact factor: 3.275

4. Mixed linear and non-linear disposition of lazabemide, a reversible and selective inhibitor of monoamine oxidase B.

Authors: T W Guentert; N H Holford; J P Pfefen; J Dingemanse
Journal: Br J Clin Pharmacol Date: 1994-06 Impact factor: 4.335

5. Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease.

Authors: A Churchyard; C J Mathias; P Boonkongchuen; A J Lees
Journal: J Neurol Neurosurg Psychiatry Date: 1997-08 Impact factor: 10.154

6. Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.

Authors: I Berlin; R Zimmer; H M Thiede; C Payan; T Hergueta; L Robin; A J Puech
Journal: Br J Clin Pharmacol Date: 1990-12 Impact factor: 4.335

7. Brain monoamine oxidase A inhibition in cigarette smokers.

Authors: J S Fowler; N D Volkow; G J Wang; N Pappas; J Logan; C Shea; D Alexoff; R R MacGregor; D J Schlyer; I Zezulkova; A P Wolf
Journal: Proc Natl Acad Sci U S A Date: 1996-11-26 Impact factor: 11.205

8. Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157.

Authors: Joanna S Fowler; Jean Logan; Albert J Azzaro; Robert M Fielding; Wei Zhu; Amy K Poshusta; Daniel Burch; Barry Brand; James Free; Mahnaz Asgharnejad; Gene-Jack Wang; Frank Telang; Barbara Hubbard; Millard Jayne; Payton King; Pauline Carter; Scott Carter; Youwen Xu; Colleen Shea; Lisa Muench; David Alexoff; Elena Shumay; Michael Schueller; Donald Warner; Karen Apelskog-Torres
Journal: Neuropsychopharmacology Date: 2009-11-04 Impact factor: 7.853

9. Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6.

Authors: Mahnaz Salsali; Andrew Holt; Glen B Baker
Journal: Cell Mol Neurobiol Date: 2004-02 Impact factor: 5.046

10. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.

Authors: P Bitsios; R W Langley; S Tavernor; K Pyykkö; M Scheinin; E Szabadi; C M Bradshaw
Journal: Br J Clin Pharmacol Date: 1998-06 Impact factor: 4.335